Literature DB >> 2932137

A place for ipratropium bromide in the treatment of severe acute asthma.

M J Ward, J T Macfarlane, D Davies.   

Abstract

Twenty-four consecutive patients admitted to hospital with severe acute asthma were studied. Eleven were given 10 mg salbutamol by nebulizer followed 2 hours later by 500 micrograms of nebulized ipratropium bromide. These patients had a greater response in PEFR than 13 patients given two doses of 10 mg salbutamol 2 hours apart.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932137     DOI: 10.1016/0007-0971(85)90071-3

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  8 in total

Review 1.  Managing asthma in hospital: cause for concern.

Authors:  P J Barnes
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

Review 2.  Discharge of the asthmatic patient.

Authors:  B A Markoff; J F MacMillan; V Kumra
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

3.  Emergency use of nebulised bronchodilator drugs in British hospitals.

Authors:  B R O'Driscoll; G M Cochrane
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

Review 4.  Respiratory and allergic disease. I.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

Review 5.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

6.  Ipratropium bromide: are patients treated with optimal therapy?

Authors:  A B Millar; A Bush; H al-Hillawi; J Goldman; D M Denison
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

7.  Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro.

Authors:  J K Ward; M G Belvisi; A J Fox; M Miura; S Tadjkarimi; M H Yacoub; P J Barnes
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 8.  Anticholinergic therapy for chronic asthma in children over two years of age.

Authors:  N J McDonald; A I Bara
Journal:  Cochrane Database Syst Rev       Date:  2003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.